Patent holdings for IPC class A61K 31/683

Total number of patents in this class: 542

10-year publication summary

41
52
58
50
51
49
38
20
30
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2035
30
Achillion Pharmaceuticals, Inc.
164
24
N.V. Nutricia
1063
22
SignPath Pharma Inc.
69
16
Aker Biomarine Human Ingredients AS
89
15
Société des Produits Nestlé S.A.
9296
9
Viking Therapeutics, Inc.
53
7
Acasti Pharma Inc.
9
6
Nutritional Therapeutics, Inc.
15
6
Tasly Pharmaceutical Group Co., Ltd.
120
6
Kao Corporation
4968
5
National Jewish Health
168
5
Nippon Suisan Kaisha, Ltd.
196
5
SRX Cardio, LLC
21
5
Janssen Sciences Ireland Unlimited Company
399
5
Merck Sharp & Dohme LLC
3749
5
Arctic Bioscience AS
8
5
Tecton Bg, Inc.
10
5
Johnson & Johnson Vision Care, Inc.
1186
4
F. Hoffmann-La Roche AG
7945
4
Other owners 353